Artículos por temáticas

The evolution of axial postural abnormality in Parkinson's disease: a 3-year longitudinal observational study

Wu Z, Hong R, Zhang Z, Zhu S, Peng Y, Zhang J, Guan Q, Pan L, Chen Y, Jin L.

Neurol Sci. 2025 Oct;46(10):5035-5047. doi: 10.1007/s10072-025-08375-5. Epub 2025 Aug 21.

Neuroprotective mechanisms of sodium butyrate in Parkinson's disease in preclinical rodent models: a systematic review and meta-analysis

Hosseini L, Farshbaf-Khalili A, Jazani AM, Maghsoumi-Norouzabad L.

Naunyn Schmiedebergs Arch Pharmacol. 2025 Oct 25. doi: 10.1007/s00210-025-04740-5. Online ahead of print.

Ethnographic evaluation of usability, understandability, and acceptance of the MY PD-CARE digital tool to facilitate Parkinson's disease symptom tracking and patients' and care partners' communications with the treating healthcare professional: the SELF-AWARE study

Antonini A, Henriksen T, Hursey A, Bergmann L, Parra JC, Odin P.

Neurol Sci. 2025 Oct;46(10):5061-5071. doi: 10.1007/s10072-025-08342-0. Epub 2025 Jul 18.

Vagus Nerve Stimulation in Movement Disorders, from Principles to a Systematic Review of Evidence

Proietti F, Ottaviani MM, Burchi E, Vivacqua G, Anzini G, Ricciuti RA, Capone F, Macefield VG, Di Lazzaro V, Marano M.

Mov Disord. 2025 Sep 30. doi: 10.1002/mds.70044. Online ahead of print.

Exploring drug interactions between newer antidepressants and medications used to treat neurological disorders

Alborghetti M, Barbieri MA, Nicoletti F, Spina E.

Expert Opin Drug Metab Toxicol. 2025 Sep 26:1-25. doi: 10.1080/17425255.2025.2566692. Online ahead of print.

Parkinson's disease beyond the brain: implications for treatments

Malekian Naeini S, Lopez MD, Fraser PE, Tandon A.

Front Aging Neurosci. 2025 Oct 9;17:1600782. doi: 10.3389/fnagi.2025.1600782. eCollection 2025.

Modeling neurodegeneration in the retina and strategies for developing pan-neurodegenerative therapies

Ward EL, Benowitz L, Brunner TM, Bu G, Cayouette M, Canto-Soler V, Dá Mesquita S, Di Polo A, DiAntonio A, Duan X, Goldberg JL, He Z, Hu Y, Liddelow SA, La Torre A, Margeta M, Quintana F, Shekhar K, St

Mol Neurodegener. 2025 Oct 14;20(1):108. doi: 10.1186/s13024-025-00858-5.

Assessing the relationship of gut microbiota with neurological, psychiatric, and neurodegenerative disorders: a narrative review

Batagianni M, Papazoglou A, Galiatsatos P, Linos D.

World J Biol Psychiatry. 2025 Oct;26(8):409-421. doi: 10.1080/15622975.2025.2530750. Epub 2025 Jul 17.

Reversible withdrawal-induced bradykinesia-rigidity in alcoholic Parkinsonism

She Y, Wang J, Liu Y, Mo L, Tan C, Liu X, Chen L.

Intern Med J. 2025 Oct;55(10):1775-1776. doi: 10.1111/imj.70218. Epub 2025 Sep 26.

Clinical MRI Biomarkers to Differentiate Parkinson Disease from Its Mimics

Haller S, He N, Schwarz S, Haacke EM.

Radiology. 2025 Oct;317(1):e242044. doi: 10.1148/radiol.242044.

The Central Cholinergic Synapse: A Primer

Klein J.

Int J Mol Sci. 2025 Oct 3;26(19):9670. doi: 10.3390/ijms26199670.

Multifaceted roles of extracellular vesicles in the interplay of neuroinflammation and neurodegenerative diseases

Deng Z, Chen H, Chen J, Du Z, Zhou W, Yuan Z.

Biochim Biophys Acta Mol Basis Dis. 2025 Oct;1871(7):167960. doi: 10.1016/j.bbadis.2025.167960. Epub 2025 Jun 27.

Gait analysis for Parkinson's disease using multiscale entropy

Amisola LRV, Acosta RJB, Arao-Arao HMD, Benitez VNC, Chan RMT, Co AKG, Cortez NSF, Galina PBF, Virata MCA.

Neurodegener Dis Manag. 2025 Oct;15(5):245-258. doi: 10.1080/17582024.2025.2510842. Epub 2025 May 26.

A longitudinal study on physical activity in early Parkinson's disease

Ng SY, Naheed D, Saffari ES, Chia NS, Choi X, Heng DL, Neo SX, Xu Z, Tay KY, Au WL, Tan EK, Tan LC.

J Parkinsons Dis. 2025 Oct 3:1877718X251380487. doi: 10.1177/1877718X251380487. Online ahead of print.

Beyond prion-like spreading in neurodegenerative disease

Meisl G, Rowe JB, Klenerman D.

Alzheimers Dement. 2025 Oct;21(10):e70789. doi: 10.1002/alz.70789.